CC

Craig Conoscenti

Professional Summary



Professional Overview


Craig Conoscenti is a seasoned pharmaceutical executive with over 30 years of experience in the life sciences industry. As the Sr Vice President at Avalyn Pharma Inc., he brings a wealth of expertise in respiratory and idiopathic pulmonary fibrosis (IPF) drug development, clinical research, and medical affairs.

Experience Summary



Current Role


In his current role as Sr Vice President at Avalyn Pharma, Craig is responsible for overseeing the clinical development and medical affairs strategies for the company's pipeline of novel therapeutic candidates targeting respiratory diseases. He leverages his extensive industry knowledge and therapeutic area leadership to drive the advancement of Avalyn's clinical programs and ensure effective medical and scientific engagement with key stakeholders.

Career Progression


Prior to joining Avalyn Pharma, Craig held various leadership positions at Boehringer Ingelheim Pharmaceuticals Inc., where he served as the Executive Director and Therapeutic Area Head for Respiratory ILD Clinical Development and Medical Affairs. In this role, he led the successful development and commercialization of several respiratory products, including treatments for IPF. Additionally, he served as a Medical Expert in ILD and Respiratory Clinical Development, as well as the Director of the Idiopathic Pulmonary Fibrosis Program Area.

Earlier in his career, Craig spent over a decade at Norwalk Hospital, where he held roles as the Chief of Diving and Hyperbaric Medicine, Medical Director of the Fairfield County Wound Healing and Hyperbaric Center, and Senior Pulmonary Critical Care Consultant in the Section of Pulmonary and Critical Care Medicine.

Academic Background


Craig holds a medical degree from Yale University School of Medicine and completed his Pulmonary Critical Care Fellowship at Hackensack University Medical Center. He also served as the Chief Resident in the Department of Internal Medicine at Hackensack University Medical Center and completed his medical internship at The Brooklyn Methodist Hospital.

Areas of Expertise


  • Respiratory disease drug development, with a focus on idiopathic pulmonary fibrosis (IPF) and interstitial lung diseases (ILD)

  • Clinical trial design, execution, and data analysis

  • Medical affairs strategy and stakeholder engagement

  • Regulatory affairs and product lifecycle management

  • Cross-functional team leadership and collaboration


Professional Impact


Throughout his career, Craig has made significant contributions to the advancement of respiratory disease research and treatment. He has led the successful development and commercialization of several respiratory products, including treatments for IPF, and has been instrumental in driving scientific and medical engagement with key stakeholders in the field.

Conclusion


With his extensive experience, deep industry expertise, and proven track record of success, Craig Conoscenti is poised to continue making a meaningful impact in the pharmaceutical industry as the Sr Vice President at Avalyn Pharma. His leadership and strategic vision will be invaluable in driving the company's efforts to develop innovative therapies for patients with respiratory and interstitial lung diseases.